Success Metrics

Clinical Success Rate

62.5%

Based on 5 completed trials

Completion Rate

63%(5/8)

Active Trials

2(17%)

Results Posted

60%(3 trials)

Terminated

3(25%)

Phase Distribution

Ph not_applicable

17%

Ph phase_3

25%

Ph phase_2

25%

Ph phase_4

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Phase 2Efficacy & side effects

3(27.3%)

Phase 3Large-scale testing

3(27.3%)

Phase 4Post-market surveillance

3(27.3%)

N/ANon-phased studies

2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(5)

Terminated(3)

Other(2)

Detailed Status

Completed5

Terminated3

unknown2

Recruiting2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

62.5%

Most Advanced

Phase 4

Trials by Phase

Phase 23 (27.3%)

Phase 33 (27.3%)

Phase 43 (27.3%)

N/A2 (18.2%)

Trials by Status

unknown217%

recruiting217%

completed542%

terminated325%

Recent Activity

2 active trials

Showing 5 of 12

recruitingphase_3

Statins In Intracerbral Hemorrhage

NCT03936361

completedphase_4

Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)

NCT00652847

unknown

Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke

NCT06134635

completedphase_2

A Study to Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFH

NCT03933293

completedphase_2

An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

NCT02890992

View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials

NCT03936361Phase 3

Statins In Intracerbral Hemorrhage

Recruiting

NCT00652847Phase 4

Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)

Completed

NCT06134635

Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke

Unknown

NCT03933293Phase 2

A Study to Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFH

Completed

NCT02890992Phase 2

An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Completed

NCT03971019Phase 3

Survival Benefits of Statins in Breast Cancer Patients

Unknown

NCT03770702Phase 3

Statins and ARBs on Rheumatoid Activity

Recruiting

NCT02642159Phase 4

Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

Completed

NCT00850460Phase 4

Quality of Life in Patients With Statin-Associated Myopathy

Terminated

NCT01972178Phase 2

Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia

Terminated

NCT00968383Not Applicable

Cardiovascular Magnetic Resonance for the Occluded Infarct-Related Artery Treatment

Terminated

NCT01738542Not Applicable

Safety and Efficacy Study of Bosentan for Intermittent Claudication in Peripheral Arterial Disease